Chemotherapy: 1,904 Real Stories

1,904 stories match chemotherapy. 1,436 of them mention surgery.

Callie, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II HR-Positive Invasive Ductal Carcinoma: Callie's Survivor Story

Patient Info: Callie, Female, Under 40 | Stage II

Biomarkers: ER-positive

As of June 2026, Callie described survivorship after mastectomy, ACT chemotherapy, reconstruction, and hysterectomy for Stage IIB ER-positive IDC, with all cancer-directed treatment completed by the end of 2019.

The Patient Story
OutcomeSurvivorship / Completed Treatment
Maria, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Maria's Survivor Story

Patient Info: Maria, Female | Stage III

Maria’s PET scan came back clear after 7 months of chemotherapy, 7 weeks of radiation, and surgery for Stage IIIC rectal cancer, but she described herself as still under surveillance with blood tests every 6 months and not cancer-free until 5 years.

The Patient Story
OutcomeSurvivorship / Surveillance
Heidi, who was diagnosed with Stage III Non-Small Cell Lung CancerLung Cancer

Stage III Non-Small Cell Lung Cancer: Heidi's Survivor Story

Patient Info: Heidi N., Female, 50s | Stage III

Biomarkers: No targetable mutation identified

As of June 2026, Heidi was featured as a lung cancer advocate after treatment for inoperable Stage IIIA NSCLC; scans through January 2021 had shown no evidence of disease.

The Patient Story
OutcomeCancer-Free / NED
Joy, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II BRCA1 Breast Cancer: Joy's Survivor Story

Patient Info: Joy R., Female | Stage II

Biomarkers: BRCA1 mutation

As of June 2026, Joy had no evidence of disease after chemotherapy, double mastectomy, and hysterectomy for Stage II breast cancer with a BRCA1 mutation, and had moved from 3-month to 6-month oncology monitoring.

The Patient Story
OutcomeCancer-Free / NED
Andrea, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Andrea's Survivor Story

Patient Info: Andrea, Female, Under 40 | Stage III

Completed chemotherapy, mastectomy/reconstruction, and radiation for Stage IIB-to-Stage III breast cancer diagnosed during pregnancy, and later described survivorship, parenting, fatigue, relationship strain, and recovery after treatment.

The Patient Story
OutcomeSurvivorship / Surveillance
Justine, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Justine's Patient Story

Patient Info: Justine, Female, Under 40 | Stage IV

Metastatic Site: Liver

As of June 2026, Justine was living with Stage IV rectal cancer involving the liver after chemoradiation, major surgery, FOLFOX, and liver-directed local therapies.

The Patient Story
OutcomeLiving With Cancer
Janice, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Triple-Negative Breast Cancer: Janice's Patient Story

Patient Info: Janice, Female, Under 40 | Stage IV

Biomarkers: ER-negative; PR-negative; HER2-negative

Metastatic Site: Other sites not specified

Living with incurable Stage IV triple-negative breast cancer while advocating for dose adjustments, symptom management, and balancing quality of life with survival.

The Patient Story
OutcomeLiving With Cancer
Bethany, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Bethany's Patient Story

Patient Info: Bethany W., Female, Under 40 | Stage IV

Metastatic Site: Bones; liver; lymph nodes; stomach

As of June 2026, Bethany was living with Stage IV metastatic breast cancer and responding well to maintenance treatment, with scans described as phenomenal and disease areas shrinking or disappearing.

The Patient Story
OutcomeResponding Well
Monica, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II Invasive Ductal Carcinoma: Monica's Survivor Story

Patient Info: Monica, Female, Under 40 | Stage II

As of June 2026, Monica described survivorship after treatment for Stage IIB breast cancer and a separate undifferentiated pleomorphic sarcoma, with lasting neuropathy, bone pain, reconstruction complications, and grief around fertility.

The Patient Story
OutcomeSurvivorship / Completed Treatment
Rach, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II HR-Positive Breast Cancer: Rach's Patient Story

Patient Info: Rach D., Female, Under 40 | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

As of June 2026, Rach described Stage II triple-positive breast cancer treated with fertility preservation, 6 rounds of neoadjuvant TCHP including Herceptin, Zoladex ovarian suppression, and double mastectomy with reconstruction.

The Patient Story
OutcomeCare Ongoing
Allison, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Allison’s Stage 2C Colorectal Cancer Story

Patient Info: Allison, Female, Under 40 | Stage II

As of June 2026, Allison was sharing her Stage IIC colorectal cancer experience as a patient advocate after concurrent radiation/Xeloda, major surgery with J-pouch and temporary ileostomy, and chemotherapy.

The Patient Story
OutcomeSurvivorship / Completed Treatment
Haley, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Haley's Survivor Story

Patient Info: Haley Pollack, Female, Under 40 | Stage III

Years into survivorship after Stage IIIC colon cancer treated with surgery, CAPOX chemotherapy, and a recurrence-prevention clinical trial; later continued trial follow-up and advocacy for parents with cancer.

The Patient Story
OutcomeSurvivorship / Surveillance
Montessa, who was diagnosed with Small Cell Lung CancerLung Cancer

Small Cell Lung Cancer: Montessa's Survivor Story

Patient Info: Montessa, Female, Under 40

As of June 2026, Montessa was sharing her recovery after limited-stage small cell lung cancer treatment with concurrent chemotherapy and radiation followed by brain radiation.

The Patient Story
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Non-Small Cell Lung CancerLung Cancer

Recurrent squamous lung cancer with tumor emboli, acute limb ischemia, brain metastases, and death

Patient Info: Anonymized, Male, 60s | Stage Metastatic/Advanced

Biomarkers: p40-positive; TTF-1-negative; PD-L1 not expressed / no PD-L1 reported in raw case

Metastatic Site: brain/cerebral metastases; tumor emboli in upper and…

The patient developed recurrent acute limb ischemia from tumor emboli, then new cerebral metastases, and died from advanced disease 7 months after the bilateral lower-limb ischemia presentation.

PubMed Central
OutcomeIn Memory
Erin, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Triple-Negative Breast Cancer: Erin's Patient Story

Patient Info: Erin, Female | Stage IV

Biomarkers: ER-negative; PR-negative; HER2-negative; later tumor responded to androgen signaling

Metastatic Site: Lung; brain

As of June 2026, Erin was living with metastatic triple-negative breast cancer involving lung and brain, with tumors shrinking on ongoing Gemzar plus carboplatin chemotherapy every 2 weeks.

The Patient Story
OutcomeResponding Well
Genoa, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III HER2-Positive Breast Cancer: Genoa's Survivor Story

Patient Info: Genoa M., Female | Stage III

Biomarkers: HER2-positive; ER-positive

As of June 2026, Genoa had completed treatment for Stage III HER2-positive, ER-positive breast cancer with neoadjuvant Taxotere/carboplatin/trastuzumab, lumpectomy, and radiation, and was focused on survivorship and rebuilding life after treatment.

The Patient Story
OutcomeSurvivorship / Completed Treatment
Shelley, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Shelley's Survivor Story

Patient Info: Shelley, Female, 40s | Stage III

Shelley completed colectomy and adjuvant chemotherapy for Stage IIIB colon cancer and was in survivorship/recovery with lingering treatment effects and follow-up needs; explicit NED status is not stated.

The Patient Story
OutcomeSurvivorship / Surveillance
Amelia, who was diagnosed with Stage I Invasive Ductal CarcinomaBreast Cancer

Stage I HR-Positive Invasive Ductal Carcinoma: Amelia's Patient Story

Patient Info: Amelia, Female, 40s | Stage I

Biomarkers: ER-positive; PR-positive; HER2-negative; BRCA negative; Oncotype DX score 22

As of June 2026, Amelia had no evidence of disease after lumpectomy, bilateral mastectomy, TC chemotherapy, and reconstruction, and she remained on tamoxifen.

The Patient Story
OutcomeCare Ongoing
Lindsay, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Lindsay's Patient Story

Patient Info: Lindsay, Female, Under 40 | Stage IV

Metastatic Site: Left ovary; lung spot

As of June 2026, Lindsay was living with Stage IV metastatic colon cancer after FOLFOX chemotherapy, surgery, maintenance chemotherapy, relapse, and a second surgery; exact later treatment details are limited in the extracted text.

The Patient Story
OutcomeLiving With Cancer
Cat, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II HR-Positive Invasive Ductal Carcinoma: Cat's Survivor Story

Patient Info: Cat, Female | Stage II

Biomarkers: ER-positive; Oncotype recurrence risk discussed

As of June 2026, Cat described being cancer-free after bilateral mastectomy, 4 months of chemotherapy, reconstruction, and a period on tamoxifen for ER-positive Stage IIB breast cancer.

The Patient Story
OutcomeCancer-Free / NED
Lee, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Lee's Patient Story

Patient Info: Lee, Male, 50s | Stage IV

Metastatic Site: Liver

Lee initially reached no evidence of disease after chemotherapy and right hemicolectomy, but the cancer recurred in the liver about 1 year later, requiring FOLFIRI and liver resection with major postoperative complications.

The Patient Story
OutcomeSetback / Progression
Renee, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Stage IV HER2-Positive Invasive Ductal Carcinoma: Renee's Patient Story

Patient Info: Renee N., Female | Stage IV

Biomarkers: HER2-positive

Metastatic Site: Brain

As of June 2026, Renee’s public story described living with metastatic HER2-positive breast cancer as a chronic illness, after brain radiation and while on Kadcyla every 3 weeks with stable scans reported in December 2019 and early March 2020.

The Patient Story
OutcomeLiving With Cancer
Tina, who was diagnosed with Stage III Invasive Lobular CarcinomaBreast Cancer

Stage III HR-Positive Invasive Lobular Carcinoma: Tina's Patient Story

Patient Info: Tina, Female, Under 40 | Stage III

Biomarkers: ER-positive

As of June 2026, Tina was in survivorship after double mastectomy, AC-T chemotherapy, radiation, and ongoing hormone therapy with daily tamoxifen and Zoladex every 3 months.

The Patient Story
OutcomeCare Ongoing
Rachel, who was diagnosed with Stage I Invasive Ductal CarcinomaBreast Cancer

Stage I Invasive Ductal Carcinoma: Rachel's Patient Story

Patient Info: Rachel, Female | Stage I

Biomarkers: Genetic testing inconclusive; receptor status not reported

As of June 2026, Rachel had completed double mastectomy and chemotherapy for Stage IB breast cancer and remained on planned 10-year tamoxifen therapy, with ongoing joint/muscle pain, weight gain, and survivorship effects.

The Patient Story
OutcomeCare Ongoing